Zongertinib

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

ANTI-CANCER COMBINATION THERAPY
- US 20250205238 A1
  申请人: BOEHRINGER INGELHEIM INT优先权: 2023
  CN
  US
  WO
  3 件公开
- US 20250228858 A1
  申请人: BOEHRINGER INGELHEIM INT优先权: 2023
  CN
  US
  WO
  3 件公开
Crystalline forms of a HER2 tyrosine kinase inhibitor
US 20250376476 A1申请人: BOEHRINGER INGELHEIM INT优先权: 2024
US
WO
2 件公开
TREATMENT OF CANCER WITH METASTASES IN THE CENTRAL NERVOUS SYSTEM
US 20260034134 A1申请人: BOEHRINGER INGELHEIM INT优先权: 2024
US
WO
2 件公开
SOLID DISPERSIONS HAVING STABILIZED EMULSION PARTICLES
US 20260096994 A1申请人: BOEHRINGER INGELHEIM INT优先权: 2024
US
WO
2 件公开
COMBINATION OF ZONGERTINIB WITH A SOS1 INHIBITOR FOR USE IN THE TREATMENT OF CANCER
WO 2025210042 A1申请人: BOEHRINGER INGELHEIM INT优先权: 2024
WO